Michael Levy, MD, PhD (@mlevy18) 's Twitter Profile
Michael Levy, MD, PhD

@mlevy18

Associate Professor, Harvard Medical School
Director, Neuroimmunology Clinic and Research Laboratory
Department of Neurology, Massachusetts General Hospital

ID: 32846168

linkhttp://massgeneral.org/nmo calendar_today18-04-2009 10:05:30

34 Tweet

867 Followers

97 Following

Michael Levy, MD, PhD (@mlevy18) 's Twitter Profile Photo

Take advantage of this #GivingTuesday to make a donation to the new NMO Clinic and Research Lab at Mass General Hospital! giving.massgeneral.org/donate/nmo-cli… Thank you for all you do! #mgh

Michael Levy, MD, PhD (@mlevy18) 's Twitter Profile Photo

MGH is the first site for Alexion’s Ultomiris trial in NMOSD. Ultomiris is a long acting version of Soliris, which requires an infusion every 2 weeks. Ultomiris would extend that to 8 weeks. The goal is to show that Ultomiris is as effective as Soliris. [email protected].

Michael Levy, MD, PhD (@mlevy18) 's Twitter Profile Photo

The Massachusetts General Hospital NMO Clinic and Research Laboratory website is now available in Mandarin and Spanish! See options in the right-hand bar. massgeneral.org/nmo MGH Neurology

Michael Levy, MD, PhD (@mlevy18) 's Twitter Profile Photo

A large study in China (including Wuhan area) found no increased risk of COVID-19 among MS and NMO patients. Out of 3,060 NMOSD patients, only 2 had COVID-19 pneumonia and both recovered. ncbi.nlm.nih.gov/pubmed/32503092

Michael Levy, MD, PhD (@mlevy18) 's Twitter Profile Photo

I am pleased to introduce the Superficial Siderosis Clinic and Research Laboratory at Massachusetts General Hospital. Please visit our new web page: massgeneral.org/neurology/trea… MGH Neurology

Michael Levy, MD, PhD (@mlevy18) 's Twitter Profile Photo

Do you or anyone you know have MOG antibody disease? Take this survey to help us assess the most effective treatments: redcap.partners.org/redcap/surveys… MGH Neurology

Michael Levy, MD, PhD (@mlevy18) 's Twitter Profile Photo

The MGH NMO Clinic and Research Lab announces 2 grants from the Sumaira Foundation! - to examine how cholesterol pathways influence MOG-AD activity - to create a simple, inexpensive NMO test for use in developing countries #mghneurology #NMO #MOG #sumairafoundation

Michael Levy, MD, PhD (@mlevy18) 's Twitter Profile Photo

Recent interview with GG deFiebre about Covid 19, the Covid vaccines and neuroimmune disorders: wearesrna.org/resources/abcs…

Michael Levy, MD, PhD (@mlevy18) 's Twitter Profile Photo

Impressive results with ravulizumab in AQP4 NMO. Zero relapses among 58 people over 73 weeks. astrazeneca.com/media-centre/p…

Michael Levy, MD, PhD (@mlevy18) 's Twitter Profile Photo

2022 Massachusetts Walk-Run-N-Roll for SRNA : Make a donation today to support 2022 Massachusetts Walk-Run-N-Roll for SRNA 2022-ma-wrnr.raisely.com/michael-levy #Massachusetts-walkrunnroll-for-srna via Raisely

Michael Levy, MD, PhD (@mlevy18) 's Twitter Profile Photo

FUNDING OPPORTUNITY ANNOUNCEMENT The Sumaira Foundation is awarding research grants (maximum award up to $25,000) to fund research engaged in research into prevention, treatments, and a cure(s) for NMOSD and MOG-AD. Deadline: September 16, 2022 sumairafoundation.org/tsf-funded-res…

Michael Levy, MD, PhD (@mlevy18) 's Twitter Profile Photo

My fellow, Anastasia Vishnevetsky, MD, MPH spends most of her time solving NMO and MOG. But in her spare time, she also saves Ukranian families! l.facebook.com/l.php?u=https%…